· NY legislature · 2025-2026
Requires practitioners to discuss certain risks with a patient who is being prescribed a controlled substance or an opioid analgesic
Requires practitioners to discuss certain risks with a patient who is being prescribed a schedule II controlled substance or an opioid analgesic; requires the department of health to develop practitioner guidelines.
- Sponsor
- Nathalia Fernández (D-NY)
- Introduced
- 2025-03-24
- Latest action
- PRINT NUMBER 6758A
Digging through Congress... 🔍